Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovoCure

11.76
+0.44003.89%
Post-market: 11.59-0.1700-1.45%19:54 EDT
Volume:2.01M
Turnover:23.15M
Market Cap:1.31B
PE:-7.54
High:11.77
Open:11.45
Low:11.13
Close:11.32
Loading ...

BUZZ-Novocure up after quarterly sales beat estimates

Reuters
·
24 Jul

NovoCure's Q2 Net Loss Widens, Revenue Rises

MT Newswires Live
·
24 Jul

Earnings Flash (NVCR) Novocure Posts Q2 Loss $0.36 a Share, vs. FactSet Est of $0.38 Loss

MT Newswires Live
·
24 Jul

Novocure Reports Q2 2025 Net Revenues Rise 6% Year-Over-Year to $159 Million; Gross Margin Declines to 74%

Reuters
·
24 Jul

NovoCure Q2 2025 EPS $(0.36) Beats $(0.39) Estimate, Sales $158.805M Beat $153.876M Estimate

Benzinga
·
24 Jul

BRIEF-Novocure Q2 Revenue USD 158.805 Million Vs. IBES Estimate USD 154.2 Million

Reuters
·
24 Jul

Novocure Q2 Operating Income USD -39.521 Million

THOMSON REUTERS
·
24 Jul

Novocure Ltd - Plans Pma Submission to FDA for Pancreatic Cancer in Q3 2025

THOMSON REUTERS
·
24 Jul

Novocure Ltd - Plans Pma Submission to FDA for Nsclc Brain Metastases

THOMSON REUTERS
·
24 Jul

Novocure Q2 Pretax Profit USD -34.979 Million

THOMSON REUTERS
·
24 Jul

J.P. Morgan Sticks to Their Hold Rating for NovoCure (NVCR)

TIPRANKS
·
22 Jul

NovoCure (NASDAQ:NVCR) shareholders are up 4.2% this past week, but still in the red over the last three years

Simply Wall St.
·
15 Jul

Ladenburg Thalmann Initiates NovoCure at Buy With $30 Price Target

MT Newswires Live
·
08 Jul

Novocure Initiated at Buy by Ladenburg Thalmann

Dow Jones
·
08 Jul

Novocure initiated with a Buy at Ladenburg

TIPRANKS
·
08 Jul

Promising Phase 3 Results for NovoCure’s TTFields Therapy in Pancreatic Cancer

TIPRANKS
·
02 Jul

Novocure Announces Positive Final Results from Phase 3 PANOVA-3 Trial of TTFields Therapy for Pancreatic Cancer Ahead of ESMO 2025 Presentation

Reuters
·
01 Jul

Novocure Ltd. to Report Second Quarter 2025 Financial Results

Reuters
·
30 Jun

Novocure Price Target Maintained With a $34.00/Share by Piper Sandler

Dow Jones
·
28 Jun

NovoCure Appoints New President at Annual Meeting

TIPRANKS
·
07 Jun